836
Views
11
CrossRef citations to date
0
Altmetric
Articles

Addressing the psychosocial needs of cancer patients: a retrospective analysis of a distress screening and management protocol in clinical care

&

References

  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology TM Distress Management V.2.2016; 2016.
  • Mehnert A, Hartung TJ, Friedrich M, et al. One in two cancer patients is significantly distressed: prevalence and indicators of distress. Psychooncology. 2018;27:75–82.
  • Carlson LE. Screening alone is not enough: The importance of appropriate triage, referral, and evidence-based treatment of distress and common problems. J Clin Oncol. 2013;31: 3616–3617.
  • Giese-Davis J, Waller A, Carlson LE, et al. Screening for distress, the 6th vital sign: Common problems in cancer outpatients over one year in usual care: associations with marital status, sex, and age. BMC Cancer. 2012;12: 441.
  • Bultz BD, Groff SL, Fitch M, et al. Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psychooncology. 2011;20: 463–469.
  • National Cancer Institute. National Cancer Institute: PDQ® adjustment to cancer: risk factors: prevalence and predictors of distress. https://www.cancer.gov/about-cancer/coping/feelings/anxiety-distress-hp-pdq. Accessed August 23, 2018.
  • Graves KD, Arnold SM, Love CL, Kirsh KL, Moore PG, Passik SD. Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress. Lung Cancer. 2007;55: 215–224.
  • Kendall J, Glaze K, Oakland S, Hansen J, Parry C. What do 1281 distress screeners tell us about cancer patients in a community cancer center? Psychooncology. 2011;20: 594–600.
  • Brown KW, Levy AR, Rosberger Z, Edgar L. Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med. 2003;65: 636–643.
  • Shim EJ, Mehnert A, Koyama A, et al. Health-related quality of life in breast cancer: a cross-cultural survey of German, Japanese, and South Korean patients. Breast Cancer Res Treat. 2006;99: 341–350.
  • Monahan PO, Champion V, Rawl S, et al. What contributes more strongly to predicting QOL during 1-year recovery from treatment for clinically localized prostate cancer: 4-weeks-post-treatment depressive symptoms or type of treatment? Qual Life Res. 2007;16: 399–411.
  • Reich M, Lesur A, Perdrizet-Chevallier C. Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat. 2008;110: 9–17.
  • Carlson LE, Bultz BD. Benefits of psychosocial oncology care: improved quality of life and medical cost offset. Health Qual Life Outcomes. 2003;1: 8.
  • Jansen F, Krebber AM, Coupe VM, et al. Cost-utility of stepped care targeting psychological distress in patients with head and neck or lung cancer. J Clin Oncol. 2017;35: 314–324.
  • Zebrack B, Kayser K, Bybee D, et al. A practice-based evaluation of distress screening protocol adherence and medical service utilization. J Natl Compr Canc Netw. 2017;15: 903–912.
  • Coyne JC. Benefits of screening cancer patients for distress still not demonstrated. Br J Cancer. 2013;108: 736–737.
  • Meijer A, Roseman M, Delisle VC, et al. Effects of screening for psychological distress on patient outcomes in cancer: a systematic review. J Psychosom Res. 2013;75: 1–17.
  • Pirl WF, Lennes IT. Quality of psychosocial services in cancer centers: today and tomorrow. Cancer. 2016;122: 1807–1808.
  • Groff S, Holroyd-Leduc J, White D, Bultz BD. Examining the sustainability of screening for distress, the sixth vital sign, in two outpatient oncology clinics: a mixed-methods study. Psychooncology. 2018; 27:141–147.
  • Institute of Medicine. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. Washington DC: National Academies Press; 2008.
  • Pirl WF, Fann JR, Greer JA, et al. Recommendations for the implementation of distress screening programs in cancer centers: report from the American Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and Oncology Nursing Society (ONS) joint task force. Cancer. 2014;120: 2946–2954.
  • American Society for Clinical Oncology. Quality Oncology Practice Initiative (QOPI®). http://www.instituteforquality.org/quality-oncology-practice-initiative-qopi. Accessed March 2, 2017.
  • Commission on Cancer. Cancer Program Standards 2012: Ensuring Patient-centered care, Version 1.2.1. Chicago, IL: American College of Surgeons; 2012.
  • Funk R, Cisneros C, Williams RC, Kendall J, Hamann HA. What happens after distress screening? Patterns of supportive care service utilization among oncology patients identified through a systematic screening protocol. Support Care Cancer. 2016;24: 2861–2868.
  • Singer S, Danker H, Roick J, et al. Effects of stepped psychooncological care on referral to psychosocial services and emotional well-being in cancer patients: a cluster-randomized phase III trial. Psychooncology. 2017;26: 1675–1683.
  • Zebrack B, Kayser K, Padgett L, et al. Institutional capacity to provide psychosocial oncology support services: a report from the Association of Oncology Social Work. Cancer. 2016;122: 1937–1945.
  • Yu-Jie C, Nien-Mu C, Liang-Jen W, et al. Prevalence and related factors of psychological distress among cancer inpatients using routine Distress Thermometer and Chinese Health Questionnaire screening. Neuropsychiatr Dis Treat. 2016;12: 2765–2773.
  • Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol. 2007;25: 4670–4681.
  • Mitchell AJ. Screening for cancer-related distress: when is implementation successful and when is it unsuccessful? Acta Oncol. 2013;52: 216–224.
  • Zebrack B, Kayser K, Sundstrom L, et al. Psychosocial distress screening implementation in cancer care: an analysis of adherence, responsiveness, and acceptability. J Clin Oncol. 2015;33: 1165–1170.
  • Hui D, Titus A, Curtis T, et al. Implementation of the Edmonton Symptom Assessment System for symptom distress screening at a community cancer center: a Pilot Program. Oncologist. 2017;22: 995–1001.
  • Ma X, Zhang J, Zhong W, et al. The diagnostic role of a short screening tool–the distress thermometer: a meta-analysis. Support Care Cancer. 2014;22: 1741–1755.
  • Oktay JS, Kayser K, Lee HY, Rohan E, Smith SK, Zebrack B. Promoting Research in Oncology Social Work: A White Paper from the Association of Oncology Social Work Post-Conference Research Institute. AOSW 32nd Annual Conference. Oncology Social Workers: A Safe Harbor in the Storm. Tampa, FL: Association of Oncology Social Work; 2016.
  • Carlson LE, Waller A, Groff SL, Zhong L, Bultz BD. Online screening for distress, the 6th vital sign, in newly diagnosed oncology outpatients: randomised controlled trial of computerised vs personalised triage. Br J Cancer. 2012;107: 617–625.
  • Carlson LE, Angen M, Cullum J, et al. High levels of untreated distress and fatigue in cancer patients. Br J Cancer. 2004;90: 2297–2304.
  • Jacobsen PB, Donovan KA, Trask PC, et al. Screening for psychologic distress in ambulatory cancer patients. Cancer. 2005;103: 1494–1502.
  • Donovan KA, Jacobsen PB. Progress in the implementation of NCCN guidelines for distress management by member institutions. J Natl Compr Canc Netw. 2013;11: 223–226.
  • Nipp RD, Zullig LL, Samsa G, et al. Identifying cancer patients who alter care or lifestyle due to treatment-related financial distress. Psychooncology. 2016;25: 719–725.
  • Meeker CR, Geynisman DM, Egleston BL, et al. Relationships among financial distress, emotional distress, and overall distress in insured patients with cancer. J Oncol Pract. 2016;12: 755–764.
  • Zafar SY. Financial toxicity of cancer care: It's time to intervene. J Natl Cancer Inst. 2016;108:370–374.
  • Zwahlen D, Tondorf T, Rothschild S, Koller MT, Rochlitz C, Kiss A. Understanding why cancer patients accept or turn down psycho-oncological support: a prospective observational study including patients’ and clinicians’ perspectives on communication about distress. BMC Cancer. 2017;17: 385–395.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.